Please login to the form below
Aplidin
This page shows the latest Aplidin news and features for those working in and with pharma, biotech and healthcare.
ViiV’s two-drug HIV combo backed by CHMP
abaloparatide) and confirming its earlier rejection of Pharma Mar’s Aplidin (plitidepsin) as a treatment for multiple myeloma.
Latest news
-
Promising new agents for multiple myeloma
Other anti-cancer agents. Plitidepsin (Aplidin; PharmaMar) induces cell death through various cellular pathways.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
-
Senior Medical Writer
-
Salary TBC
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
Subscribe to our email news alerts
- Key success factor (KSF)
- Genital herpes vaccine candidate heads for human studies
- Sangamo steps up BioMarin chase with haemophilia gene therapy data
- PMEA 2019 Winners Gallery - PMEA
- Sanofi’s new CEO cuts first deal, adding Synthorx for $2.5bn
- J&J and Bristol-Myers Squibb/Bluebird bio reveal rival CAR-T data
- Frontera proud finalists for the 2020 PM Awards
- Brexit nears as Conservatives sweep to victory in election
- Roche’s Tecentriq combo scores in first-line melanoma
- House Democrats finally pass landmark drug pricing bill
- UPDATED: Senate officially confirms Stephen Hahn as FDA commissioner
- FDA grants surprise OK to Sarepta’s DMD therapy after earlier rejection
PMHub
Create Health
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...
Latest intelligence
- The 2019 CPhI Pharma Index Report
- Examining this year’s industry performance...
- Five key trends in precision and personalised healthcare
- Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Quick links
Infographics
